The most widely used serum marker for colon cancer (carcinoembryonic antigen) remains a useful modality to assess for occult disease following curative resection. Identification of tumor mutations ...

Proliferating cells, in particular tumor cells, express a dimeric isoenzyme of pyruvate kinase, termed Tumor M2 pyruvate kinase. In the last few years, much attention has been paid to this novel ...

Exploring the link between liver cirrhosis and liver metastasis in colorectal cancer. Systematic literature review (SLR) of prognostic factors (PFs) in locally advanced rectal cancer (LARC) and ...

A new research paper was published in Oncotarget’s Volume 16 on January 21, 2025, titled “Assessment of cfDNA release ...

Explore how cfDNA levels change around colorectal cancer surgery and their potential as non-invasive biomarkers for ...

Biological and therapeutic impact of tumor mutational burden in microsatellite instability/mismatch repair-deficient (MSI/dMMR) metastatic colorectal cancer (mCRC) treated with immune checkpoint ...

In order to increase awareness of the need of identifying symptoms and promptly seeking medical assistance, Radwah Oda discusses her experience of failing to recognize early signs of stage 4 colon ...

Medicare now covers Guardant Reveal for monitoring colorectal cancer recurrence after ... analysis to detect circulating tumor DNA (ctDNA), a marker of minimal residual disease (MRD).